|
HS2ST1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.082400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.545600E-01 |
| Normal-vs-Stage2 |
7.218200E-01 |
| Normal-vs-Stage3 |
7.142000E-01 |
| Normal-vs-Stage4 |
7.943800E-01 |
| Stage1-vs-Stage2 |
6.229400E-01 |
| Stage1-vs-Stage3 |
8.628000E-01 |
| Stage1-vs-Stage4 |
6.780600E-01 |
| Stage2-vs-Stage3 |
5.845800E-01 |
| Stage2-vs-Stage4 |
9.647200E-01 |
| Stage3-vs-Stage4 |
6.431800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.999600E-01 |
| Normal-vs-AfricanAmerican |
9.880600E-01 |
| Normal-vs-Asian |
6.390000E-01 |
| Caucasian-vs-AfricanAmerican |
9.886000E-01 |
| Caucasian-vs-Asian |
6.894600E-01 |
| AfricanAmerican-vs-Asian |
6.631600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.140000E-01 |
| Normal-vs-Female |
1.439980E-01 |
| Male-vs-Female |
9.652100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.896400E-01 |
| Normal-vs-Extreme_Weight |
3.012200E-01 |
| Normal-vs-Obese |
5.106800E-01 |
| Normal-vs-Extreme_Obese |
8.199400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.891200E-01 |
| Normal_Weight-vs-Obese |
2.745000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.575800E-01 |
| Extreme_Weight-vs-Obese |
1.580370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.916000E-01 |
| Obese-vs-Extreme_Obese |
9.906200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.693000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.714800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.848600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.737600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.368200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.879200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.965200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.108100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.434600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.783000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.870600E-01 |
| Normal-VS-Type2 PRCC |
5.252600E-01 |
| Normal-VS-KIRP CIMP |
5.927800E-01 |
| Normal-VS-Unclassified PRCC |
4.827400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.044400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.553000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.508600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.823200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.757800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.845600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.160100E-02 |
| Normal-vs-N1 |
9.318000E-01 |
| Normal-vs-N2 |
4.501600E-01 |
| N0-vs-N1 |
2.755400E-01 |
| N0-vs-N2 |
6.548000E-02 |
| N1-vs-N2 |
3.263600E-01 |
|
|
